FDA approves Radiesse
FDA Approves Wrinkle Filler;A Rival Frowns
FDA Approves Wrinkle Filler; A Rival Frowns - WSJ.com
Recently Updated Weblogs
December 2008
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Categories
« November 2006 | Main | January 2007 »
December 2006
December 27, 2006
December 23, 2006
U.S. Researcher Penalized for Drug Maker Ties
U.S. Researcher Penalized for Drug Maker Ties
U.S. Researcher Penalized for Drug Maker Ties - New York Times
It pays to report all of your financial affiliations with other entities
If you are consulting for a pharmaceutical company, this must be reported
December 19, 2006
Writings of Gordon Clark
The Truth: by Gordon David Clark - Homepage
Gordon Clark, a patient of mine, has an interesting side to him. I wanted to share his writings with the rest of the world. Caution is advised... I do not condone or condemn his ideas.
December 17, 2006
New Guidlines for Pertussis Vaccination of Adults
Guidelines Issued for Adult Tetanus-Diphtheria-Pertussis (Tdap) Vaccination
From our friends at Physician First Watch:
The guidelines, published in MMWR, suggest the Tdap vaccine be given:
• to adults aged 19 to 64 to replace the tetanus and diphtheria toxoids vaccine (Td) for booster immunization if they got their last dose of the older vaccine at least 10 years earlier
• at intervals of less than 10 years for those at increased risk for pertussis
• to child-care providers and other adults having close contact with infants (ideally before pregnancy for mothers)
• to health care workers with direct patient contact
For the last three groups, the CDC recommends an interval as short as 2 years from the last dose of Td, and says shorter intervals may be used.Ketek with Safety Concerns
Sanofi Antibiotic Takes Hit From FDA Advisers - WSJ.com
Ketek should no longer be marketed for sinusitis or bronchitis, because the drug's risks outweigh its benefits for those infections.
The drug has been linked to serious, though rare, cases of liver failure and damage, as well as severe risk to patients with myasthenia gravis, a neuromuscular disease. A few people taking Ketek have also suffered blurred vision and loss of consciousness
December 16, 2006
Mozy is the bomb
Personal Technology -- Personal Technology from The Wall Street Journal.
More on the merits of Mozy
December 10, 2006
December 07, 2006
Flatulence leads to an emergency landing
Flatulence Forces Plane to Land - New York Times
The passenger was not charged for lighting a match to conceal her fart..
